ABSTRACT
Approximately 10-30% of population suffers from allergic rhinitis during their lifetime. In India, more than 10% of the population is reported to have one or other type of allergic disorder. Nasal symptoms are often demeaned; however, their prevalence and effect on the quality of life justify an aggressive and rational approach. Rhinitis and asthma frequently co-exist [60-70%] with rhinitis appearing first in 45% of patients. We wanted to study prevalence of bronchial asthma in patients of allergic rhinitis with or without chest symptoms and its correlates. METHODSThis is a cross sectional study conducted among 100 cases of allergic rhinitis who presented to our hospital from December 2010 to August 2012. Data was analysed by using SPSS and results were expressed in percentages. RESULTSMaximum number of patients belonged to the age group between 21 - 25 yrs. (34 patients), where males were 38.18% and females were 28.89%. Majority of the patients (74%) had significantly reversible small airways obstruction. Among the patients with allergic rhinitis, males had predominantly chest symptoms (58.33%) compared to females (41.67%). Spirometry revealed 63 (80.77%) patients had mild obstruction, 12 (15.38 %) had moderate obstruction and 3 (3.85 %) had severe obstruction. The prevalence of asthma among allergic rhinitis was found to be 78% in our study. CONCLUSIONS78% of patients with allergic rhinitis were found to have underlying asthma. Prevalence of severe, moderate, and mild asthma amongst patients of allergic rhinitis was found to be 3%, 12% and 63% respectively. Severe obstruction was observed in 3.85% of subjects.
ABSTRACT
We report on 3 patients who presented with symptoms of Ki obstruction, Ki deficiency, and disorder of the body's fluid metabolism, successfully treated with bukuryoingohangekobokuto. In our experience, bukuryoingohangekobokuto has been effective in 25 of the 30 patients (6 men and 24 women) to whom is has been administered, who also presented with Ki obstructions, Ki deficiencies and disorders of the body's fluid metabolism as mentioned above. The most common subjective symptom in all these effectively-treated patients was hot flashes. Other signs were epigastric pain or discomfort accompanied by chest signs and symptoms, such as palpitations, heartburn, chest oppression or dyspnea. The most common objective findings in these effectively-treated patients were pulsation at the pit of the stomach and navel, and a fluid sound in the stomach upon palpation. Based on our experiences, we believe that prescription of bukuryoingohangekobokuto is best indicated when the presence of the above-mentioned symptoms and findings has been confirmed.
ABSTRACT
OBJECTIVES: To determine the yield of bronchoscopy for evaluating tracheobronchial spread in esophageal carcinoma and to identify the conditions for bronchoscopy in patients with newly diagnosed esophageal carcinoma, who planned to be operated. METHODS: From March 1989 to June 1997, 115 patients with esophageal carcinoma had received bronchoscopy. Bronchoscopic findings were classified into three types: Type I: no definitive endobronchial lesion, Type II: indirect effects(hyperemia and compression), Type III: invasion. CT findings were classified into three classes: Class A: tumor separated from tracheobronchial tree, Class B: abutting tree, Class C: compressing tree. We investigated the correlations of clinical presentation and non-invasive tests (including esophagogram) with bronchoscopic findings. RESULTS: 1) Among 115 patients, bronchoscopic findings were Type I in 67(58.3%), Type II in 34(29.6%), Type III in 14(12.2%). 2) Abnormal bronchoscopic findings are related with length of lesion by esophagogram.(p < 0.05) 3) Class C lesion by chest CT scan were closely correlated with abnormal bronchoscopic findings. 4) Chest symptoms were frequently associated with type III lesion of bronchoscopy CONCLUSION: We could recommend preoperative bronchoscopy in recently diagnosed as esophageal carcinoma who got more than 2 of 3 variables listed below: 1) patients who had chest symptoms, such as cough with sputum, hemoptysis, and dyspnea 2) length of tumor is long in esophagogram(above 5 cm in length), 3) tracheobronchial compressed lesion by chest CT scan. Bronchoscopy is not needed in cases with no chest symptom, short lesion length(below 5 cm) and normal chest CT finding for preoperative evaluation of esophageal carcinoma.